metformin and n(1)-methylnicotinamide

metformin has been researched along with n(1)-methylnicotinamide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Auge, D; Fromm, MF; Hoier, E; Maas, R; Mieth, M; Müller, F; Pontones, CA; Renner, B; Zolk, O	1
Bahrami-Asl, Z; Fattahi, A; Latifi, Z; Mihanfar, A; Nejabati, HR; Nouri, M; Roshangar, L; Samadi, N; Shahnazi, V	1
Feng, B; Mathialagan, S; Rodrigues, AD; Varma, MVS	1

Trials

1 trial(s) available for metformin and n(1)-methylnicotinamide

Article	Year
N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction. European journal of clinical pharmacology, 2015, Volume: 71, Issue:1 Topics: Adult; Blood Glucose; Creatinine; Cross-Over Studies; Drug Interactions; Female; HEK293 Cells; Humans; Hypoglycemic Agents; Kidney; Male; Metformin; Niacinamide; Organic Cation Transport Proteins; Trimethoprim; Young Adult	2015

Article

Year

N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.

European journal of clinical pharmacology, 2015, Volume: 71, Issue:1

Topics: Adult; Blood Glucose; Creatinine; Cross-Over Studies; Drug Interactions; Female; HEK293 Cells; Humans; Hypoglycemic Agents; Kidney; Male; Metformin; Niacinamide; Organic Cation Transport Proteins; Trimethoprim; Young Adult

2015

Other Studies

2 other study(ies) available for metformin and n(1)-methylnicotinamide

Article	Year
Nicotinamide and its metabolite N1-Methylnicotinamide alleviate endocrine and metabolic abnormalities in adipose and ovarian tissues in rat model of Polycystic Ovary Syndrome. Chemico-biological interactions, 2020, Jun-01, Volume: 324 Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Cytokines; Estrous Cycle; Female; Gene Expression; Glucose Transporter Type 4; Hyperandrogenism; Luteinizing Hormone; Metformin; Niacinamide; Nicotinamide Phosphoribosyltransferase; Ovary; Polycystic Ovary Syndrome; Rats, Wistar; Resistin; Steroid 17-alpha-Hydroxylase; Testosterone	2020
Drug-Drug Interactions Involving Renal OCT2/MATE Transporters: Clinical Risk Assessment May Require Endogenous Biomarker-Informed Approach. Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:4 Topics: Acidosis, Lactic; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antiviral Agents; Area Under Curve; Biomarkers; Creatinine; Drug Interactions; HEK293 Cells; Histamine H2 Antagonists; Humans; Hypoglycemic Agents; In Vitro Techniques; Metformin; Niacinamide; Organic Cation Transport Proteins; Organic Cation Transporter 2; Proton Pump Inhibitors; Renal Elimination	2021

Article

Year

Nicotinamide and its metabolite N1-Methylnicotinamide alleviate endocrine and metabolic abnormalities in adipose and ovarian tissues in rat model of Polycystic Ovary Syndrome.

Chemico-biological interactions, 2020, Jun-01, Volume: 324

Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Cytokines; Estrous Cycle; Female; Gene Expression; Glucose Transporter Type 4; Hyperandrogenism; Luteinizing Hormone; Metformin; Niacinamide; Nicotinamide Phosphoribosyltransferase; Ovary; Polycystic Ovary Syndrome; Rats, Wistar; Resistin; Steroid 17-alpha-Hydroxylase; Testosterone

2020

Drug-Drug Interactions Involving Renal OCT2/MATE Transporters: Clinical Risk Assessment May Require Endogenous Biomarker-Informed Approach.

Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:4

Topics: Acidosis, Lactic; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antiviral Agents; Area Under Curve; Biomarkers; Creatinine; Drug Interactions; HEK293 Cells; Histamine H2 Antagonists; Humans; Hypoglycemic Agents; In Vitro Techniques; Metformin; Niacinamide; Organic Cation Transport Proteins; Organic Cation Transporter 2; Proton Pump Inhibitors; Renal Elimination

2021